MAVCERTIX Trademark

Trademark Overview

On Wednesday, January 20, 2021, a trademark application was filed for MAVCERTIX with the United States Patent and Trademark Office. The USPTO has given the MAVCERTIX trademark a serial number of 90476842. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by X4 Pharmaceuticals, Inc.. The MAVCERTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia; Pharmaceutical preparations for the treatment of Waldenström's macroglobulinemia; Pharmaceutical preparations for the treatment of cancer
mavcertix

General Information

Serial Number90476842
Word MarkMAVCERTIX
Filing DateWednesday, January 20, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia; Pharmaceutical preparations for the treatment of Waldenström's macroglobulinemia; Pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameX4 Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02134
Party NameX4 Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02134

Trademark Events

Event DateEvent Description
Wednesday, August 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 23, 2021NEW APPLICATION ENTERED
Wednesday, April 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 3, 2021ASSIGNED TO EXAMINER
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 31, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 29, 2022SOU EXTENSION 1 FILED
Friday, April 29, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 31, 2022SOU EXTENSION 2 FILED
Monday, October 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 31, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 31, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, April 30, 2023SOU EXTENSION 3 FILED
Sunday, April 30, 2023SOU TEAS EXTENSION RECEIVED
Sunday, April 30, 2023SOU EXTENSION 3 GRANTED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 28, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 28, 2023SOU EXTENSION 4 FILED
Saturday, October 28, 2023SOU EXTENSION 4 GRANTED
Tuesday, October 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

mavcertix pharmaceutical treatment preparations macroglobulinemia cancer waldenstr syndrome whim immunodeficiencies neutropenia